➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
AstraZeneca
Medtronic
Harvard Business School
Colorcon

Last Updated: August 9, 2020

DrugPatentWatch Database Preview

MICONAZOLE 7 Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Miconazole 7, and what generic alternatives are available?

Miconazole 7 is a drug marketed by P And L and Cosette and is included in two NDAs.

The generic ingredient in MICONAZOLE 7 is miconazole nitrate. There are twenty-eight drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the miconazole nitrate profile page.

US ANDA Litigation and Generic Entry Outlook for Miconazole 7

A generic version of MICONAZOLE 7 was approved as miconazole nitrate by ACTAVIS PHARMA on November 19th, 1993.

  Start Trial

Drug patent expirations by year for MICONAZOLE 7
Drug Sales Revenue Trends for MICONAZOLE 7

See drug sales revenues for MICONAZOLE 7

Recent Clinical Trials for MICONAZOLE 7

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Abond CRO Inc.Phase 2/Phase 3
Hill Dermaceuticals, Inc.Phase 2/Phase 3
William N HandelmanPhase 2

See all MICONAZOLE 7 clinical trials

US Patents and Regulatory Information for MICONAZOLE 7

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
P And L MICONAZOLE 7 miconazole nitrate CREAM;VAGINAL 074164-001 Mar 29, 1996 OTC No No   Start Trial   Start Trial   Start Trial
Cosette MICONAZOLE 7 COMBINATION PACK miconazole nitrate CREAM, SUPPOSITORY;TOPICAL, VAGINAL 076585-001 Mar 26, 2004 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Merck
Dow
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.